News

Labcorp Launches FDA-Approved PD-L1 Companion Diagnostic for KEYTRUDA Ovarian Cancer Treatment

FDA · 2 min

Dupixent Becomes First Biologic Approved for Children Ages 2-11 with Chronic Spontaneous Urticaria

2 min

AACR 2026: ctDNA, Immunotherapy, and KRAS Target Breakthroughs

oncology · 12 min

Denali Therapeutics Receives FDA Approval for Avlayah (Tividenofusp Alfa) to Treat Hunter Syndrome

Hunter syndrome (MPS II) · 3 min

Pfizer Presents LORBRENA and BRAFTOVI Cancer Trial Updates at ASCO 2026

2 min

Boston Scientific Reports Strong Q1 2026 Results with $5.2 Billion Revenue, 11.6% Growth

2 min

Ractigen Therapeutics RAG-17 Shows 81% Reduction in ALS Biomarker in Phase I Trial

Neurology - Amyotrophic Lateral Sclerosis (ALS) · 3 min

Avacta's AVA6103 Cancer Drug Shows Superior Profile vs Enhertu in AACR 2026 Data

2 min

Innovent Biologics IBI363 Clinical Data to Be Presented at ASCO 2026 Annual Meeting

2 min

FDA Extends Sanofi Sarclisa Subcutaneous Review by Three Months for Multiple Myeloma Treatment

2 min

NRx Pharmaceuticals Receives Positive FDA Feedback on Preservative-Free Ketamine Generic Drug Application

FDA · 3 min

Lupin Launches Generic Dapagliflozin-Metformin XR Tablets in US as Xigduo XR Alternative

2 min